Abstract:For both in situ or ex situ regeneration of tissues to be repaired,an ideal tissue engineering scaffold should create a local environment to facilitate homing,induced differentiation,and proliferation in addition to its molding function.For a tissue engineering scaffold to achieve this objective,releasing the relevant cell growth factors for sufficient period of time is more efficient and natural over that by material morphology.However,protein drugs are delicate and easily denatured by the harsh conditions of preparation for tissue engineering scaffolds,which may evoke undesirable antibody responses.None of the tissue engineering scaffolds reported to date have achieved long-term sustained-release of cell growth factor proteins in native conformation.To overcome this still-standing hurdle,the present study demonstrated a method to load cytokine proteins into tissue-engineering fibers with preserved native conformation for achieving long term sustained-release.We first preloaded vascular endothelial growth factor (VEGF165) as the model protein into dextran nanoparticles without contacting water-oil or water-gas interface (recognized protein conformation killer) by utilizingthe freezing induced aqueous phase separation method developed in our lab.Then the VEGF165 protected in the matrix of dextran particles were suspended in a solution of poly (lactic-co-glycolic acid) (PLGA) prior to electrospinning to form fibers.In order to avoid burst release in the initial stage by the protein-preloaded particles exposed at the fiber surface,another layer of PLGA fiber which carried no VEGF165 was spanned on the top of the already formed PLGA fiber membrane.A series of physicochemical characterizations comprising scanning electron microscopy (SEM),contact angle,mechanical strength,confirmed that the tissue engineering fibers formed above possessed satisfied surface texture and mechanical strength.The VEGF165 was recovered after each of the preparation step and assayed using CCK-8 test for bioactivity.The results indicated that the VEGF165 recovered from the dextran nanoparticles retained＞97 ％ bioactivity,and that from the final fiber was above 87 ％,both were remarkably higher than that recovered from the fibers formed in which the protein was preloaded in solution form (＜55 ％).In vitro release test showed that nanoparticles composite fibers prepared as above achieved a sustained-release profile with minimal initial burst and un-released residue.The protein was released less than 35 ％ of the total load in the initial five days and over 92％ at day 25.For the fibers wherein VEGF16s was loaded in the solution form,the 53.12 ％ of protein load was released in the initial five days,and 84.52 ％ was released at day 25.The therapeutic efficacy of the VEGF165 loaded fiber membranes were examined on the rat model of lowerlimb ischemia,followed immunohistochemistry observation.The results indicated that the regenerated blood vessels by dextran nanoparticles composite PLGA fibers were significantly more than that by the fibers to which VEGF165 was loaded in solution form.As conclusion,pre-loading proteins in polysaccharide nanoparticles prior to electrospinning was an effective method to prepare efficacious tissue engineere fibers for sustained-release cell growth factored with preserved bioactivity and improved release kinetics.

The preparation of melt electrospun fiber containing tandospirone for drug sustained release

Potential of alginate fibers incorporated with drug-loaded nanocapsules as drug delivery systems

Electrospinning of Biomacromolecules for Controlled Drug Release

Electrospun Fibers with Blank Surface and Inner Drug Gradient for Improving Sustained Release.

Advanced 3D Electrospinning “Xspin” System: Fabrication of Bifiber Floating Oral Pharmaceutical Scaffolds for Controlled Drug Delivery

Electrospun Nanofiber and Cryogel of Polyvinyl Alcohol Transdermal Patch Containing Diclofenac Sodium: Preparation, Characterization and In Vitro Release Studies

PEDOT: PSS‐Based Microfluidic‐Spun Microfibers for Tunable Release of Acetaminophen via Electrical Stimulation

Preparation and Protein Sustained-release System of Electrospinning Nanofibers

Engineered Spindles of Little Molecules Around Electrospun Nanofibers for Biphasic Drug Release

Influence of Sorbitan Monooleate on Morphology and Drug Release Behavior of Emulsion Electrospinning Polycaprolactone Nanofibers

Preparation of Fiber Mats of Hydroxybutyrate-Co-Hydroxyoctanoate and Drug Microspheres by Electrostastic Technique

Long-term drug release from electrospun fibers for in vivo inflammation prevention in the prevention of peritendinous adhesions.

Investigation of Drug Release and Matrix Degradation of Electrospun Poly(<scp>dl</scp>-lactide) Fibers with Paracetanol Inoculation

Mechanism of a Long-Term Controlled Drug Release System Based on Simple Blended Electrospun Fibers

Encapsulation of Drug Reservoirs in Fibers by Emulsion Electrospinning: Morphology Characterization and Preliminary Release Assessment

Electrospun Polymer Blend Nanofibers for Tunable Drug Delivery: The Role of Transformative Phase Separation on Controlling the Release Rate

Sustained Release of Dicumarol via Novel Grafted Polymer in Electrospun Nanofiber Membrane for Treatment of Peritendinous Adhesion (Adv. Healthcare Mater. 15/2023)

Sustained release of a thiosemicarbazone from antibacterial electrospun poly(lactic‐co‐glycolic acid) fiber mats

Electrospinning of alginate/soy protein isolated nanofibers and their release characteristics for biomedical applications

Advancing inflammatory skin disease therapy: Sustained tofacitinib release via electrospun fiber dressings

Teaching experimental design and development of a novel drug loading system based on temperature-sensitive material and electrospinning technique